XML 42 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Jun. 30, 2022
May 17, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Assets, Current [Abstract]                    
Cash and cash equivalents $ 4,732       $ 3,702       $ 109  
Marketable securities, available-for-sale 419       3,808       0  
Prepaid expenses and other current assets 418       619       565  
Total current assets 5,569       8,129       674  
Other assets 0       206       279  
Total assets 5,569       8,335       955  
Liabilities, Current [Abstract]                    
Accounts payable 1,185       918       1,226  
Accrued expenses 700       1,430       847  
Warrant liability 225   $ 225   0          
Other current liabilities 0       97       105  
Total current liabilities 2,110       2,445       2,225  
Other liabilities 0       72       170  
Total liabilities 2,110       2,517       2,409  
Commitments and contingencies (Note 9)                
Stockholders' equity (deficit):                    
Common stock, $0.0001 par value; 250,000,000 shares authorized; 6,812,836 and 4,506,216 shares issued and outstanding as of December 31, 2021 and 2020, respectively 1       0       0  
Additional paid-in-capital 30,802       27,722       11,145  
Accumulated other comprehensive loss (1)       (2)       0  
Accumulated deficit (27,343)       (21,902)       (12,599)  
Total stockholders' equity (deficit) 3,459 $ 3,666   $ 3,360 5,818 $ 8,729 $ 9,853 $ 12,027 (1,454) $ 3,214
Total liabilities and stockholders' equity (deficit) $ 5,569       $ 8,335       $ 955